peptides

dart board miss failure
Biotech

GemVax's peptide drug fails phase 2a neurodegenerative trial

Korea's GemVax revealed that its peptide drug candidate GV1001 missed the mark in a phase 2a study in progressive supranuclear palsy.
Fraiser Kansteiner Oct 29, 2024 11:28am
Photo of Wall Street street sign with american flags in the background

MBX aims for $136M IPO to take rival to Ascendis into phase 3

Sep 9, 2024 11:59am
Graphic image of the letters IPO in white in front of a yellow background

MBX files for IPO to take challenger to Ascendis into phase 3

Aug 26, 2024 9:40am
An artists concept of chains of amino acides called peptides which together make up polypeptides or proteins

Baker Lab AI makes strides in drug-like peptides

Apr 25, 2024 2:00pm
Bands of money scattered all over the frame

Genentech signs off on $1B biobucks to expand PeptiDream collab

Sep 20, 2023 7:14am
Missed target failed trial trial failure

Theratechnologies halts lead cancer trial over efficacy concerns

Dec 2, 2022 5:35am